ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8(+) T Cell Cytotoxicity

As one of the primary therapeutic choices, chemotherapy is widely adopted for progressive gastric cancer (GC), but the development of chemoresistance has limited chemotherapy efficacy and partly contributes to poor prognosis. Immunotherapy is increasingly being applied in the clinical treatment of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Cao, Tianyu, Zhang, Xiaohui, Hui, Juan, Wang, Chen, Zhang, Wenyao, Wang, Pei, Zhou, Yun, Han, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535133/
https://www.ncbi.nlm.nih.gov/pubmed/36213324
http://dx.doi.org/10.1155/2022/6863240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535133/
https://www.ncbi.nlm.nih.gov/pubmed/36213324
http://dx.doi.org/10.1155/2022/6863240

Ejemplares similares